Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice modelAmanda Cano, María L. García, Marta Barenys et al.|Journal of Controlled Release|2019Cited by 330
Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative DiseasesAmanda Cano, Patric Turowski, Elena Sánchez‐López et al.|Nanomedicine|2020Cited by 137
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challengesAmanda Cano, Merçé Boada, Marta Marquié et al.|Journal of Nanobiotechnology|2021Cited by 122
Endothelial MAPKs Direct ICAM-1 Signaling to Divergent Inflammatory FunctionsSilvia Dragoni, Patric Turowski|The Journal of Immunology|2017Cited by 55
Endothelial Protease Activated Receptor 1 (PAR1) Signalling Is Required for Lymphocyte Transmigration across Brain Microvascular Endothelial CellsSilvia Dragoni, Patric Turowski|Cells|2020Cited by 10